1. Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

   • Paola Giordano
   • Paola Saracco
   • Angelo Claudio Molinari

   Review Article 25 August 2015 Pages: 1765 - 1776

   

2. Anemia among Muslim Bedouin and Jewish women of childbearing age in Southern Israel

   • Yulia Treister-Goltzman
   • Roni Peleg
   • Aya Biderman

   Original Article 28 July 2015 Pages: 1777 - 1784

3. Incidence of testicular microlithiasis in patients with β-thalassemia major

   • Rahil Rahimi
   • Amin Abolhasani Foroughi
   • Mehran Karimi

   Original Article 08 August 2015 Pages: 1785 - 1789

   

4. Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results

   • Francisco Cervantes
   • Ignacio M. Isola
   • Arturo Pereira

   Original Article 28 June 2015 Pages: 1791 - 1796

5. Transfusion dependency at diagnosis and transfusion intensity during initial chemotherapy are associated with poorer outcomes in adult acute myeloid leukemia

   • Giovanna Cannas
   • Jihane Fattoum
   • Xavier Thomas

   Original Article 23 July 2015 Pages: 1797 - 1806

   

6. Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines

   • Domenico Mastrangelo
   • Lauretta Massai
   • Giovanni Grasso

   Original Article 12 August 2015 Pages: 1807 - 1816

   

7. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival

   • Lan Yuan
   • Ling Lu
   • Liming Bao

   Original Article 05 September 2015 Pages: 1817 - 1828

   

8. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

   • Yinjun Lou
   • Yafang Ma
   • Jie Jin

   Original Article 22 August 2015 Pages: 1829 - 1837

   

9. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment

   • Felicitas Hitz
   • J. M. Connors
   • R. Klasa

   Original Article 07 August 2015 Pages: 1839 - 1843

   

10. Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial

    • Byeong-Bae Park
    • Won Seog Kim
    • Won Sik Lee

    Original Article 08 August 2015 Pages: 1845 - 1851

    

11. The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma

    • M. Madle
    • I. Krämer
    • M. Witzens-Harig

    Original Article 14 August 2015 Pages: 1853 - 1857

    

12. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma

    • Amandine Segot
    • Emmanuel Raffoux
    • Thomas Cluzeau

    Original Article 18 August 2015 Pages: 1859 - 1863

13. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP

    • Yu Wang
    • Ya-Jun Li
    • Zhi-Ming Li

    Original Article 02 September 2015 Pages: 1865 - 1873

    

14. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

    • A. Romano
    • N. L. Parrinello
    • I. Borrello

    Original Article 31 July 2015 Pages: 1875 - 1883

    

15. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses

    • Minako Mori
    • Yoshimori An
    • Kazunori Imada

    Original Article 08 August 2015 Pages: 1885 - 1890

    

16. Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

    • Agnieszka Piekarska
    • Lidia Gil
    • Andrzej Hellmann

    Original Article Open access 29 July 2015 Pages: 1891 - 1897

    

17. Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

    • A. Tschan-Plessl
    • J. P. Halter
    • S. Gerull

    Original Article 02 August 2015 Pages: 1899 - 1905

    

18. Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo

    • Gregor Blank
    • Christian Welker
    • Karin Schilbach

    Original Article 13 August 2015 Pages: 1907 - 1919

    

19. Is a liver-spleen scan helpful in the evaluation of patients with thrombocytopenia?

    • Kartik Anand
    • Reinhold Munker

    Letter to the Editor 15 July 2015 Pages: 1921 - 1922

20. Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia

    • Olivia Geiger
    • Stefan Hatzl
    • Armin Zebisch

    Letter to the Editor 25 July 2015 Pages: 1923 - 1924

    

21. Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome

    • Che-Hung Lin
    • Su-Peng Yeh
    • Tze-Yi Lin

    Letter to the Editor 02 August 2015 Pages: 1925 - 1926

    

22. Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

    • Elisa Rumi
    • Jelena D. Milosevic
    • Mario Cazzola

    Letter to the Editor 23 July 2015 Pages: 1927 - 1928

    

23. JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib

    • Anne Koehler
    • Karolin Hubert
    • Haifa Kathrin Al-Ali

    Letter to the Editor 23 July 2015 Pages: 1929 - 1930

    

24. Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study

    • Sara Bigliardi
    • Monica Morselli
    • Fabio Forghieri

    Letter to the Editor 25 July 2015 Pages: 1931 - 1934

25. Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma

    • Naoto Tomita
    • Masataka Taguri
    • Yoshiaki Ishigatsubo

    Letter to the Editor 25 July 2015 Pages: 1935 - 1937

    

26. Disseminated extranodal marginal zone lymphoma involving the gastrocnemius muscle with sural neurolymphomatosis

    • Pooja Advani
    • Liuyan Jiang
    • James Foran

    Letter to the Editor 22 July 2015 Pages: 1939 - 1940

    

27. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting

    • Min Shi
    • Stephen Spurgeon
    • Guang Fan

    Letter to the Editor 02 August 2015 Pages: 1941 - 1944